Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
$0.70 -0.03 (-4.52%)
Closing price 04:00 PM Eastern
Extended Trading
$0.70 +0.00 (+0.17%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TLRY vs. ACB, CGC, CRON, OGI, SNDL, IBRX, APLS, XENE, NAMS, and BHC

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), ImmunityBio (IBRX), Apellis Pharmaceuticals (APLS), Xenon Pharmaceuticals (XENE), NewAmsterdam Pharma (NAMS), and Bausch Health Cos (BHC). These companies are all part of the "pharmaceutical products" industry.

Tilray Brands vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

In the previous week, Tilray Brands had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 13 mentions for Tilray Brands and 3 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.46 beat Aurora Cannabis' score of 0.08 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
3 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.6% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tilray Brands has a consensus price target of $1.92, suggesting a potential upside of 172.72%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
Tilray Brands
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.10$1.63M$0.1143.73
Tilray Brands$788.94M0.90-$244.98M-$1.05-0.67

Aurora Cannabis has a net margin of 1.32% compared to Tilray Brands' net margin of -113.85%. Aurora Cannabis' return on equity of 0.13% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis1.32% 0.13% 0.10%
Tilray Brands -113.85%-7.40%-6.02%

Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500.

Summary

Aurora Cannabis beats Tilray Brands on 10 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$740.88M$10.52B$5.70B$9.48B
Dividend YieldN/A1.99%4.59%3.99%
P/E Ratio-0.6716.9627.9019.95
Price / Sales0.9026.78442.18102.66
Price / CashN/A23.2136.5558.97
Price / Book0.173.688.635.90
Net Income-$244.98M$234.77M$3.24B$258.42M
7 Day Performance14.97%4.35%3.22%1.94%
1 Month Performance84.08%7.74%10.72%12.02%
1 Year Performance-60.74%-2.64%34.94%20.81%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
1.9037 of 5 stars
$0.70
-4.5%
$1.92
+172.7%
-61.1%$740.88M$788.94M-0.672,650Upcoming Earnings
Options Volume
ACB
Aurora Cannabis
0.4267 of 5 stars
$4.48
-2.3%
N/A-20.4%$251.54M$246.72M40.681,130
CGC
Canopy Growth
0.4751 of 5 stars
$1.10
-6.4%
N/A-85.7%$201.34M$225.65M-0.273,150
CRON
Cronos Group
2.4138 of 5 stars
$2.04
-1.7%
N/A-16.1%$784.86M$117.61M15.66450News Coverage
Positive News
OGI
Organigram Global
0.6897 of 5 stars
$1.44
-3.0%
N/A-11.7%$192.20M$117.47M14.35860
SNDL
SNDL
1.9844 of 5 stars
$1.53
-3.5%
$3.63
+137.7%
-30.1%$400.74M$671.81M-5.262,516News Coverage
Upcoming Earnings
IBRX
ImmunityBio
2.0236 of 5 stars
$2.75
-5.3%
$12.25
+346.3%
-47.1%$2.42B$31.22M-4.73590
APLS
Apellis Pharmaceuticals
4.3205 of 5 stars
$19.28
-3.2%
$39.79
+106.4%
-46.0%$2.42B$781.37M-10.77770Upcoming Earnings
XENE
Xenon Pharmaceuticals
3.7751 of 5 stars
$31.54
-3.3%
$54.82
+73.8%
-28.8%$2.42B$9.43M-9.76210Positive News
Options Volume
NAMS
NewAmsterdam Pharma
3.632 of 5 stars
$21.45
-3.3%
$42.89
+100.0%
+26.6%$2.41B$47.14M-11.414
BHC
Bausch Health Cos
2.8312 of 5 stars
$6.41
+1.0%
$7.30
+14.0%
-12.2%$2.37B$9.63B-58.3220,700Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners